Activation of urocortin 1 and ghrelin signaling in the basolateral amygdala induces anxiogenesis

NeuroReport

Volumn 25, Issue 1, 2014, Pages 60-64

  Currie, Paul J ^a   Schuette, Lindsey M ^a   Wauson, Shelby E R ^a   Voss, William N ^a   Angeles, Mark J ^a  

^a REED COLLEGE   (United States)

Author keywords

amygdala; anxiety; corticotropin related peptide; ghrelin; neuropeptide; urocortin

Indexed keywords

GHRELIN; UROCORTIN I;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BASOLATERAL AMYGDALA; CONTROLLED STUDY; ENZYME ACTIVITY; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

AMYGDALA; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; GHRELIN; MALE; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; UROCORTINS;

EID: 84889889233     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/WNR.0000000000000047     Document Type: Article

References (25)

1. Keck ME. Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety. Animo Acids 2006; 31:241-250
2. Donner NC, Johnson PI, Fitz SD, Kellen KE, Shekhar A, Lowry CA. Elevated tph2 mRNA expression in a rat model of chronic anxiety. Depress Anxiety 2012; 29:307-319
3. Neufeld-Cohen A, Tsoory MM, Evans AK, Getselter D, Gil S, Lowry CA, et al. A triple urocortin knockout mouse model reveals an essential role for urocortins in stress recovery. Proc Natl Acad Sci USA 2010; 107: 19020-19025
4. Yang L, Tovote P, Rayner M, Kockskamper J, Pieske B, Spiess J. Corticotrophin-releasing factor receptors and urocortins, links between the brain and the heart. Eur J Pharmacol 2010; 632:1-6
5. Spiga F, Lightman SL, Shekhar A, Lowry CA. Injections of urocortin 1 into the basolateral amygdala induce anxiety-like behavior and c-Fos expression in brainstem serotonergic neurons. Neuroscience 2006; 138:1265-1276
6. Gehlert DR, Shekhar A, Morin SM, Hipskind PA, Zink C, Gackenheimer SL, et al. Stress and central urocortin increase anxiety-like behavior in the social interaction test via the CRFI receptor. Eur J Pharmacol 2005; 509:145-153
7. Johnson PL, Sajdk TJ, Fitz SD, Hale MW, Lowry CA, Hay-Schmidt A, Shekhar A. Angiotensin II's role in sodium lactate-induced panic-like responses in rats with repeated urocortin 1 injections into the basolateral amygdala. Prog Neuropsychopharmacol Biol Psychiatry 2013; 44: 248-256
8. Dono LM, Currie PJ. The cannabinoid receptor CB(1) inverse agonist AM251 potentiates the anxiogenic activity of urocortin I in the basolateral amygdala. Neuropharmacology 2012; 62:192-199
9. Currie PJ, Khelemsky R, Rigsbee EM, Dono LM, Coiro CD, Chapman CD, Hinchcliff K. Ghrelin is an orexigenic peptide and elicits anxiety-like behaviors following administration into discrete regions of the hypothalamus. Behav Brain Res 2012; 226:96-105
10. Muccioli G, Tscho?p M, Papotti M, Deghenghi R, Heiman M, Ghigo E. Neuroendocrine and peripheral activities of ghrelin: Implications in metabolism and obesity. Eur J Endocrinol 2002; 440:235-254
11. Hansson C, Haage D, Taube M, Egecioglu E, Salome N, Dickson SL. Central administration of ghrelin alters emotional responses in rats: Behavioural, electrophysiological and molecular evidence. Neuroscience 2011; 180:201-211
12. Bruder ED, Jacobson L, Raff H. Plasma leptin and ghrelin in the neonatal rat: Interaction of dexamethasome and hypoxia. J Endocrinol 2005; 185: 477-484
13. Kanehisa M, Akiyoshi J, Kitaichi T, Matsushita H, Tanaka E, Kodama K, et al. Administration of antisense DNA for ghrelin causes an antidepressant and anxiolytic response in rats. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30:1403-1407
14. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. New York: Academic Press; 2007
15. Asakawa A, Inui A, Kaga T, Yuzuriha H, Nagata T, Fujimiya M, et al. A role of ghrelin in neuroendocrine and behavioral responses to stress in mice. Neuroendocrinology 2001; 74:143-147
16. Currie PJ, Coiro CD, Duenas R, Guss JL, Mirza A, Tal N. Urocortin I inhibits the effects of ghrelin and neuropeptide Y on feeding and energy substrate utilization. Brain Res 2011; 1385:127-134
17. Qi XR, Kamphuis W, Wang SS, Wang Q, Lucassen PJ, Zhou JN, Swabb DF. Aberrant stress hormone receptor balance in the human prefrontal cortex and hypothalamic paraventricular nucleus of depressed patients. Psychoneuroendocrinology 2013; 38:863-870
18. Uschold-Schmidt N, Nyuyki KD, Fuchsl AM, Neumann ID, Reber SO. Chronic psychosocial stress results in sensitization of the HPA axis to acure heterotypic stressors despite a reduction of adrenal in vitro ACTH responsiveness. Psychoneuronedocrinology 2012; 37:1676-1687
19. Ventura-Silva AP, Melo A, Ferreira AC, Carvalho MM, Campos FL, Sousa N, Pego JM. Excitotoxic lesions of the central nucleus of the amygdala attenuate stress-induced anxiety behavior. Front Behav Neurosci 2013; 7:1-7
20. Herman JP. Neural pathways of stress integration relevance to alcohol abuse. Alcohol Res Curr Rev 2012; 34:441-447
21. Lutter M, Sakata I, Osborne-Lawrence S, Rovinsky SA, Anderson JG, Jung S, et al. The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nat Neurosci 2008; 11:752-753
22. Spencer SJ, Xu L, Clarke MA, Lemus M, A Reichenbach, Geenen B, et al. Ghrelin regulates the hypothalamic-pituitary-adrenal axis and restricts anxiety after acute stress. Biol Psychiatry 2012; 72:457-465
23. Alvarez-Crespo M, Skibicka KP, Farkas I, Molná r CS, Egecioglu E, Hrabovszky E, et al. The amygdala as a neurobiological target for ghrelin in rats: Neuroanatomical, electrophysiological and behavioral evidence. PLoS One 2012; 7:e46321
24. Strasser F. Clinical application of ghrelin. Curr Pharm Des 2012; 18: 4800-4812
25. Schellekens H, Finger BC, Dinan TG, Cryan JF. Ghrelin signalling and obesity: At the interface of stress, mood and food reward. Pharmacol Ther 2012; 135:316-326